Dec 31 - Novavax Inc said on Friday it had submitted data to the U.S. Food and Drug Administration for emergency use authorization of its COVID-19 vaccine, with the company expecting to submit a formal request in one month. (Reporting by Leroy Leo in Bengaluru; Editing by Aditya Soni)